Entinostat

Entinostat is a medication being studied primarily for its potential use in cancer treatment. It belongs to a class of drugs known as histone deacetylase (HDAC) inhibitors, which help to modify the way genes are expressed in cells. By altering gene activity, entinostat can potentially slow the growth of cancer cells and enhance the effectiveness of other treatments, such as immunotherapy. Researchers are exploring its use in various cancers, looking to improve patient outcomes and provide new options for those with hard-to-treat conditions.